Pranaya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
- Paid Up Capital ₹ 12.89 Cr
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Pranaya Life Sciences
Pranaya Life Sciences Private Limited (PLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2018 (Six years and 11 months 20 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Govinda Balineni, Kanigiri Gade, and Sainadh Thatiparthi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999TG2018PTC122688
- Company No.
122688
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2018
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pranaya Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govinda Balineni  | Director | 23-Jun-2021 | Current |
| Kanigiri Gade | Director | 08-Jul-2023 | Current |
| Sainadh Thatiparthi | Director | 23-Jun-2021 | Current |
Financial Performance of Pranaya Life Sciences.
Pranaya Life Sciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pranaya Life Sciences?
In 2019, Pranaya Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Admiron Life Sciences Private LimitedGovinda Balineni, Kanigiri Gade and 1 more are mutual person
Aarishi Medkare Private LimitedGovinda Balineni, Kanigiri Gade and 1 more are mutual person
- Pranaya Parenterals Private Limited
Kanigiri Gade and Sainadh Thatiparthi are mutual person
- Intertech Labs Private Limited
Kanigiri Gade and Sainadh Thatiparthi are mutual person
- Neokind Health Care Private Limited
Sainadh Thatiparthi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pranaya Life Sciences?
Unlock and access historical data on people associated with Pranaya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranaya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranaya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
